Kimelman & Baird’s Pfizer PFE Stock Holding History

Kimelman & Baird’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Hold	42,976	–	–	0.08%	72
2026 Q1	$1.21M	Sell	42,976 -1,915	-4%	-$51K	0.1%	64
2025 Q4	$1.12M	Sell	44,891 -275	-0.6%	-$6.93K	0.09%	66
2025 Q3	$1.15M	Sell	45,166 -1,200	-3%	-$29.6K	0.09%	65
2025 Q2	$1.12M	Sell	46,366 -325	-0.7%	-$7.58K	0.09%	67
2025 Q1	$1.18M	Hold	46,691	–	–	0.1%	65
2024 Q4	$1.24M	Sell	46,691 -250	-0.5%	-$6.78K	0.1%	63
2024 Q3	$1.36M	Hold	46,941	–	–	0.11%	62
2024 Q2	$1.31M	Buy	+46,941	New	+$1.29M	0.11%	59
2017 Q2	–	Sell	-6,253	Closed	-$203K	–	122
2017 Q1	$203K	Buy	+6,253	New	+$197K	0.03%	116
2016 Q4	–	Sell	-6,253	Closed	-$201K	–	122
2016 Q3	$201K	Sell	6,253 -211	-3%	-$7.05K	0.04%	101
2016 Q2	$216K	Buy	+6,464	New	+$206K	0.04%	93
2016 Q1	–	Sell	-7,113	Closed	-$218K	–	113
2015 Q4	$218K	Buy	+7,113	New	+$224K	0.04%	100
2015 Q2	$300K	Sell	9,415 -2,211	-19%	-$72.1K	0.05%	96
2015 Q1	$384K	Hold	11,626	–	–	0.07%	88
2014 Q4	$344K	Buy	11,626 +454	+4%	+$13K	0.06%	93
2014 Q3	$313K	Sell	11,172 -1,240	-10%	-$34.8K	0.06%	95
2014 Q2	$350K	Sell	12,412 -795	-6%	-$22.7K	0.06%	93
2014 Q1	$402K	Hold	13,207	–	–	0.08%	82
2013 Q4	$384K	Hold	13,207	–	–	0.07%	84
2013 Q3	$360K	Hold	13,207	–	–	0.07%	86
2013 Q2	$351K	Buy	+13,207	New	+$365K	0.07%	85

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kimelman & Baird's PFE Position: Q2 2026 in Review

Kimelman & Baird held its Pfizer (PFE) position steady in Q2 2026 at 42,976 shares worth $1.03M. The position accounts for 0.08% of the portfolio, ranked #72.

Kimelman & Baird first reported a position in PFE in Q2 2013 and has held it in 22 quarters since. The position peaked at $1.36M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kimelman & Baird held 42,976 shares of Pfizer worth $1.03M as of Q2 2026.
Kimelman & Baird left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.08% of Kimelman & Baird's portfolio in Q2 2026, its #72 holding.
Kimelman & Baird first reported a position in Pfizer in Q2 2013 and has held it in 22 quarters since.
Kimelman & Baird's Pfizer position peaked at $1.36M in Q3 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.